126 related articles for article (PubMed ID: 11315594)
21. Investigation of iodine-123-labelled amino acid derivatives for imaging cerebral gliomas: uptake in human glioma cells and evaluation in stereotactically implanted C6 glioma rats.
Samnick S; Richter S; Romeike BF; Heimann A; Feiden W; Kempski O; Kirsch CM
Eur J Nucl Med; 2000 Oct; 27(10):1543-51. PubMed ID: 11083545
[TBL] [Abstract][Full Text] [Related]
22. Value of 123I-IMT SPECT for diagnosis of recurrent non-astrocytic intracranial tumours.
Plotkin M; Amthauer H; Eisenacher J; Wurm R; Michel R; Wust P; Stockhammer F; Röttgen R; Gutberlet M; Ruf J; Felix R
Neuroradiology; 2005 Jan; 47(1):18-26. PubMed ID: 15630586
[TBL] [Abstract][Full Text] [Related]
23. L-3-[123I]iodo-alpha-methyl-tyrosine SPECT in non-small cell lung cancer: preliminary observations.
Jager PL; Groen HJ; van der Leest A; van Putten JW; Pieterman RM; de Vries EG; Piers DA
J Nucl Med; 2001 Apr; 42(4):579-85. PubMed ID: 11337545
[TBL] [Abstract][Full Text] [Related]
24. Iodine-123 alpha-methyl tyrosine single-photon emission tomography of cerebral gliomas: standardised evaluation of tumour uptake and extent.
Weckesser M; Griessmeier M; Schmidt D; Sonnenberg F; Ziemons K; Kemna L; Holschbach M; Langen K; Müller-Gärtner H
Eur J Nucl Med; 1998 Feb; 25(2):150-6. PubMed ID: 9473263
[TBL] [Abstract][Full Text] [Related]
25. Assessment of clinical usefulness of 131I alpha-methyl-tyrosine and fused SPECT/MRI imaging for diagnostics of recurrent cerebral gliomas.
Górska-Chrzastek M; Grzelak P; Bieńkiewicz M; Tybor K; Zakrzewska E; Mikołajczak R; Stefańczyk L; Kuśmierek J
Nucl Med Rev Cent East Eur; 2004; 7(2):135-41. PubMed ID: 15968600
[TBL] [Abstract][Full Text] [Related]
26. 3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET.
Langen KJ; Ziemons K; Kiwit JC; Herzog H; Kuwert T; Bock WJ; Stöcklin G; Feinendegen LE; Müller-Gärtner HW
J Nucl Med; 1997 Apr; 38(4):517-22. PubMed ID: 9098193
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of recurrent squamous cell carcinoma of the head and neck with FDG positron emission tomography.
Li P; Zhuang H; Mozley PD; Denittis A; Yeh D; Machtay M; Smith R; Alavi A
Clin Nucl Med; 2001 Feb; 26(2):131-5. PubMed ID: 11201470
[TBL] [Abstract][Full Text] [Related]
28. Expression of L amino acid transport system 1 and analysis of iodine-123-methyltyrosine tumor uptake in a pancreatic xenotransplantation model using fused high-resolution-micro-SPECT-MRI.
von Forstner C; Zuhayra M; Ammerpohl O; Zhao Y; Tiwari S; Jansen O; Kalthoff H; Henze E; Egberts JH
Hepatobiliary Pancreat Dis Int; 2011 Feb; 10(1):30-7. PubMed ID: 21269932
[TBL] [Abstract][Full Text] [Related]
29. 18F-FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma.
Yi JS; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY; Roh JL
J Surg Oncol; 2012 Nov; 106(6):708-12. PubMed ID: 22674652
[TBL] [Abstract][Full Text] [Related]
30. Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers.
Vermeersch H; Loose D; Ham H; Otte A; Van de Wiele C
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1689-700. PubMed ID: 14574516
[TBL] [Abstract][Full Text] [Related]
31. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography.
Farber LA; Benard F; Machtay M; Smith RJ; Weber RS; Weinstein GS; Chalian AA; Alavi A; Rosenthal DI
Laryngoscope; 1999 Jun; 109(6):970-5. PubMed ID: 10369292
[TBL] [Abstract][Full Text] [Related]
32. Preoperative assessment of cervical lymph nodes in head and neck cancer with fluorine-18 fluorodeoxyglucose using a dual-head coincidence camera: a pilot study.
Stokkel MP; ten Broek FW; van Rijk PP
Eur J Nucl Med; 1999 May; 26(5):499-503. PubMed ID: 10382094
[TBL] [Abstract][Full Text] [Related]
33. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism.
Booij J; Speelman JD; Horstink MW; Wolters EC
Eur J Nucl Med; 2001 Mar; 28(3):266-72. PubMed ID: 11315592
[TBL] [Abstract][Full Text] [Related]
34. Single photon emission tomography: scintigraphy in the assessment of mandibular invasion by head and neck cancer.
Zieron JO; Lauer I; Remmert S; Sieg P
Head Neck; 2001 Nov; 23(11):979-84. PubMed ID: 11754503
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of FDG single-photon emission computed tomography: Computed tomography in the diagnosis of head and neck cancers and study of its mechanism.
Li LF; Zhou SH; Zhao K; Wang SQ; Wu QL; Fan J; Cheng KJ; Ling L
Cancer Biother Radiopharm; 2008 Dec; 23(6):701-14. PubMed ID: 19317609
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine.
Kuwert T; Woesler B; Morgenroth C; Lerch H; Schäfers M; Palkovic S; Matheja P; Brandau W; Wassmann H; Schober O
J Nucl Med; 1998 Jan; 39(1):23-7. PubMed ID: 9443732
[TBL] [Abstract][Full Text] [Related]
37. Differentiation between recurrent brain tumour and post-radiation necrosis: the value of 201Tl SPET versus 18F-FDG PET using a dual-headed coincidence camera--a pilot study.
Stokkel M; Stevens H; Taphoorn M; Van Rijk P
Nucl Med Commun; 1999 May; 20(5):411-7. PubMed ID: 10404525
[TBL] [Abstract][Full Text] [Related]
38. Initial evaluation of the feasibility of single photon emission tomography with p-[123 I]iodo-L-phenylalanine for routine brain tumour imaging.
Samnick S; Hellwig D; Bader JB; Romeike BF; Moringlane JR; Feiden W; Kirsch CM
Nucl Med Commun; 2002 Feb; 23(2):121-30. PubMed ID: 11891465
[TBL] [Abstract][Full Text] [Related]
39. Direct comparison of F-18-FDG PET and ultrasound in the follow-up of patients with squamous cell cancer of the head and neck.
Goerres GW; Haenggeli CA; Allaoua M; Albrecht SR; Dulguerov P; Becker M; Allal AS; Lehmann W; Slosman DO
Nuklearmedizin; 2000 Dec; 39(8):246-50. PubMed ID: 11189902
[TBL] [Abstract][Full Text] [Related]
40. Does 18fluoro-fluorodeoxyglucose positron emission tomography improve recurrence detection in patients treated for head and neck squamous cell carcinoma with negative clinical follow-up?
Salaun PY; Abgral R; Querellou S; Couturier O; Valette G; Bizais Y; Kraeber-Bodéré F
Head Neck; 2007 Dec; 29(12):1115-20. PubMed ID: 17636537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]